跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUBUTEX buprenorphine 0.4mg (as hydrochloride) tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
SUBUTEX buprenorphine 0.4mg (as hydrochloride) tablet blister pack
Approved
STANDARD
SUBUTEX buprenorphine 0.4mg (as hydrochloride) tablet blister pack
Indivior Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
d5ea7ef212a7dc4b
Company
Indivior Pty Ltd
Type
Standard
Approval Details
Approval Id
d5ea7ef212a7dc4b
Product Name
SUBUTEX buprenorphine 0.4mg (as hydrochloride) tablet blister pack
Artg Id
76661
Artg Name
SUBUTEX buprenorphine 0.4mg (as hydrochloride) tablet blister pack
Sponsor
Indivior Pty Ltd
Company Detail Path
/organization/indivior-pty-ltd
Artg Date
2000-11-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/36f7b1dc1dfbad5e689a8d449dce6020.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c9ae1a104e0fbce8deaf35a5f2805edc.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
d5ea7ef212a7dc4b
Type
Standard
Back to TGA Approvals